Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 10 studies | 38% ± 16% | |
astrocyte | 10 studies | 36% ± 16% | |
epithelial cell | 5 studies | 25% ± 11% | |
microglial cell | 4 studies | 29% ± 12% | |
GABAergic neuron | 3 studies | 29% ± 8% | |
glutamatergic neuron | 3 studies | 34% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 9089.07 | 2642 / 2642 | 99% | 97.41 | 701 / 705 |
intestine | 98% | 4662.90 | 947 / 966 | 99% | 50.83 | 522 / 527 |
stomach | 86% | 2071.26 | 308 / 359 | 98% | 47.02 | 280 / 286 |
esophagus | 88% | 1814.04 | 1278 / 1445 | 74% | 30.63 | 135 / 183 |
bladder | 86% | 2114.76 | 18 / 21 | 69% | 21.83 | 350 / 504 |
ovary | 98% | 2380.19 | 176 / 180 | 56% | 8.27 | 242 / 430 |
uterus | 68% | 695.58 | 115 / 170 | 55% | 8.12 | 251 / 459 |
adrenal gland | 57% | 720.93 | 147 / 258 | 61% | 11.23 | 141 / 230 |
skin | 20% | 202.76 | 368 / 1809 | 96% | 41.13 | 455 / 472 |
lung | 41% | 416.50 | 236 / 578 | 68% | 11.93 | 788 / 1155 |
prostate | 63% | 780.13 | 154 / 245 | 41% | 3.94 | 204 / 502 |
ureter | 0% | 0 | 0 / 0 | 100% | 23.14 | 1 / 1 |
pancreas | 1% | 6.74 | 2 / 328 | 92% | 27.72 | 164 / 178 |
eye | 0% | 0 | 0 / 0 | 90% | 39.00 | 72 / 80 |
lymph node | 0% | 0 | 0 / 0 | 90% | 13.27 | 26 / 29 |
kidney | 25% | 381.39 | 22 / 89 | 63% | 8.17 | 564 / 901 |
spleen | 85% | 904.26 | 204 / 241 | 0% | 0 | 0 / 0 |
breast | 22% | 208.08 | 100 / 459 | 60% | 6.74 | 673 / 1118 |
tonsil | 0% | 0 | 0 / 0 | 67% | 10.73 | 30 / 45 |
thymus | 21% | 200.75 | 137 / 653 | 46% | 6.10 | 276 / 605 |
adipose | 27% | 250.37 | 330 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 26% | 442.58 | 238 / 929 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 21% | 4.12 | 85 / 406 |
blood vessel | 16% | 152.83 | 213 / 1335 | 0% | 0 | 0 / 0 |
heart | 13% | 118.18 | 111 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0048545 | Biological process | response to steroid hormone |
GO_0048477 | Biological process | oogenesis |
GO_0043401 | Biological process | steroid hormone receptor signaling pathway |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005886 | Cellular component | plasma membrane |
GO_0005515 | Molecular function | protein binding |
GO_0005496 | Molecular function | steroid binding |
GO_0003707 | Molecular function | nuclear steroid receptor activity |
Gene name | PAQR8 |
Protein name | Membrane progestin receptor beta (mPR beta) (Lysosomal membrane protein in brain 1) (Membrane progesterone P4 receptor beta) (Membrane progesterone receptor beta) (Progesterone and adipoQ receptor family member 8) (Progestin and adipoQ receptor family member 8) (Progestin and adipoQ receptor family member VIII) Alternative protein PAQR8 Progestin and adipoQ receptor family member 8 |
Synonyms | LMPB1 MPRB C6orf33 |
Description | FUNCTION: Plasma membrane progesterone (P4) receptor coupled to G proteins . Seems to act through a G(i) mediated pathway . May be involved in oocyte maturation (By similarity). Also binds dehydroepiandrosterone (DHEA), pregnanolone, pregnenolone and allopregnanolone . . |
Accessions | D6RCM7 ENST00000360726.3 Q8TEZ7 L8EBD2 ENST00000512121.1 ENST00000442253.3 |